Novo CEO pressed by Senate to cut costs of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would take into account new talks with insurers about the listing price ranges of Wegovy and copyright should they pledge to help keep the medicines on their https://kethek.com/